Stay updated on Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Sign up to get notified when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.

Latest updates to the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe web page has updated its version from v2.15.0 to v2.15.2 and changed the date from April 1, 2025, to April 29, 2025.SummaryDifference0.7%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated to reflect a new version, changing from v2.14.4 to v2.15.0.SummaryDifference1.0%
- Check38 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.3%
- Check81 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check89 days agoChange DetectedThe date has been updated from February 20, 2024, to February 12, 2025.SummaryDifference0.6%
- Check96 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
Stay in the know with updates to Esketamine Safety in Treatment-Resistant Depression Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Esketamine Safety in Treatment-Resistant Depression Clinical Trial page.